Screener
ResMed Inc. RMD Income Statement
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| $418.41M+20.0% | $383.43M+1.0% | $398.73M+9.2% | $392.59M+13.9% | $348.54M+11.9% | ||
| $2.92+23.2% | $2.64+2.3% | $2.74+10.5% | $2.68+14.5% | $2.37+12.3% | ||
| $494.73M+0.1% | $493.49M-4.8% | $558.79M+18.9% | $541.55M+16.8% | $494.24M+14.4% | ||
| $452.98M+1.4% | $448.71M-1.3% | $499.81M+17.3% | $491.66M+17.8% | $446.54M+15.3% |
FAQ
- What is ResMed Inc.'s revenue?
- ResMed Inc. (RMD) generated $5.7B in revenue over the trailing twelve months, up 9.0% year over year.
- Is ResMed Inc. profitable?
- ResMed Inc. reported $1.6B in net income over the trailing twelve months, a 27.8% net margin.
- What are ResMed Inc.'s profit margins?
- Gross margin is 61.1% and operating margin is 33.0%, with a 27.8% net margin.
- What is ResMed Inc.'s earnings per share?
- ResMed Inc.'s diluted EPS over the trailing twelve months is $10.98.
- Where does ResMed Inc.'s income statement data come from?
- Every line is extracted from ResMed Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
